IMVT

IMVT

USD

Immunovant Inc. Common Stock

$24.190+0.810 (3.464%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$23.380

Máximo

$24.530

Mínimo

$23.310

Volumen

1.45M

Fundamentos de la Empresa

Capitalización de Mercado

4.2B

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

1.71M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $12.72Actual $24.190Máximo $32.1

Noticias Relacionadas

GlobeNewswire

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (NASDAQ:IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m.

Ver más
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
Analyst Upgrades

Truist Securities Initiates Coverage On Immunovant with Hold Rating, Announces Price Target of $16

Truist Securities analyst Danielle Brill initiates coverage on Immunovant with a Hold rating and announces Price Target of $16.

Ver más
Truist Securities Initiates Coverage On Immunovant with Hold Rating, Announces Price Target of $16

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.